| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |